Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent

FEBS Journal

Volumn 273, Issue 16, 2006, Pages 3743-3755

  Takeuchi, Kenji ^a   Motoda, Yu Ichiro ^a   Ito, Fumiaki ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Activator protein 1 (AP1); Adriamycin; Bcl XL; Epidermal growth factor; MAP kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 9; CYTOCHROME C; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DNA DAMAGE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR AP-1;

EID: 33746701986     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05377.x     Document Type: Article

References (53)

1. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES & Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
2. Tsujimoto Y, Finger LR, Yunis J, Nowell PC & Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226, 1097-1099.
3. Yang E & Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88, 386-401.
4. Golstein P (1997) Controlling cell death. Science 275, 1081-1082.
5. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP & Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
6. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT & Thompson CB (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
7. Jan MS, Liu HS & Lin YS (1999) Bad overexpression sensitizes NIH/3T3 cells to undergo apoptosis which involves caspase activation and ERK inactivation. Biochem Biophys Res Commun 264, 724-729.
8. Li X, Marani M, Yu J, Nan B, Roth JA, Kagawa S, Fang B, Denner L & Marcelli M (2001) Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 61, 186-191.
9. Schecter RL, Alaoui-Jamali MA & Batist G (1992) Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem Cell Biol 70, 349-353.
10. Takano H, Kohno K, Matsuo K, Matsuda T & Kuwano M (1992) DNA topoisomerase-targeting antitumor agents and drug resistance. Anticancer Drugs 3, 323-330.
11. Xia Z, Dickens M, Raingeaud J, Davis RJ & Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
12. Kulik G & Weber MJ (1998) Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol 18, 6711-6718.
13. Bryckaert M, Guillonneau X, Hecquet C, Courtois Y & Mascarelli F (1999) Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene 18, 7584-7593.
14. Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID & Rosen EM (1998) Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17, 131-141.
15. Geier A, Beery R, Haimsohn M, Hemi R, Malik Z & Karasik A (1994) Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin. In Vitro Cell Dev Biol Anim 30A, 867-874.
16. Fang M, Liu B, Schmidt M, Lu Y, Mendelsohn J & Fan Z (2000) Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells. Anticancer Res 20, 103-111.
17. Meisenhelder J, Suh PG, Rhee SG & Hunter T (1989) Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57, 1109-1122.
18. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK & Wong AJ (1996) A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564.
19. Jost M, Huggett TM, Kari C, Boise LH & Rodeck U (2001) Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J Biol Chem 276, 6320-6326.
20. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE & Reusch JE (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275, 10761-10766.
21. Deng X, Ruvolo P, Carr B & May WS Jr (2000) Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci USA 97, 1578-1583.
22. Minshall C, Arkins S, Freund GG & Kelley KW (1996) Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol 156, 939-947.
23. Yao R & Cooper GM (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
24. del Peso L, Gonzalez-Garcia M, Page C, Herrera R & Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
25. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J & Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
26. Marte BM & Downward J (1997) PKB/ Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22, 355-358.
27. Karin M, Liu Z & Zandi E (1997) AP-1 function and regulation. Curr Opin Cell Biol 9, 240-246.
28. Jacobs-Helber SM, Wickrema A, Birrer MJ & Sawyer ST (1998) AP1 regulation of proliferation and initiation of apoptosis in erythropoietin- dependent erythroid cells. Mol Cell Biol 18, 3699-3707.
29. Sevilla L, Zaldumbide A, Pognonec P & Boulukos KE (2001) Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families. Histol Histopathol 16, 595-601.
30. Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF & Nunez G (1997) Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 158, 4750-4757.
31. Kamakura S, Moriguchi T & Nishida E (1999) Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. J Biol Chem 274, 26563-26571.
32. Brown EJ & Schreiber SL (1996) A signaling pathway to translational control. Cell 86, 517-520.
33. Takeuchi K & Ito F (2004) Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3′-OH kinase-Akt pathway. J Biol Chem 279, 892-900.
34. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y & Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241.
35. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S & Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
36. Reed JC (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34, 9-19.
37. Adams JM & Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
38. Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G, Iwanaga Y, Yamamoto N, Ohtani K, Nakamura M et al. (1999) Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J Virol 73, 7981-7987.
39. Chen F, Demers LM, Vallyathan V, Lu Y, Castranova V & Shi X (1999) Involvement of 5′-flanking κB-like sites within bcl-x gene in silica-induced Bcl-x expression. J Biol Chem 274, 35591-35595.
40. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T & Karin M (1988) Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332, 166-171.
41. Ryder K, Lanahan A, Perez-Albuerne E & Nathans D (1989) jun-D: a third member of the jun gene family. Proc Natl Acad Sci USA 86, 1500-1503.
42. Hirai SI, Ryseck RP, Mechta F, Bravo R & Yaniv M (1989) Characterization of junD: a new member of the jun proto-oncogene family. EMBO J 8, 1433-1439.
43. Curran T & Teich NM (1982) Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein. J Virol 42, 114-122.
44. Cohen DR & Curran T (1988) fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol 8, 2063-2069.
45. Nishina H, Sato H, Suzuki T, Sato M & Iba H (1990) Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 87, 3619-3623.
46. Zerial M, Toschi L, Ryseck RP, Schuermann M, Muller R & Bravo R (1989) The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 8, 805-813.
47. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P & Karin M (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739.
48. Shaw PE, Schroter H & Nordheim A (1989) The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56, 563-572.
49. Gupta P & Prywes R (2002) ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression. J Biol Chem 277, 50550-50556.
50. Karin M & Lin A (2002) NF-κB at the crossroads of life and death. Nat Immunol 3, 221-227.
51. Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID & Rosen EM (2005) Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24, 1749-1766.
52. L expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci USA 94, 5067-5072.
53. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W & Kalden JR (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22, 5506-5507.